Patents by Inventor Junshun GAO

Junshun GAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240385194
    Abstract: The present invention provides a biomarker: Cyfra21-1, CEA, CA125, or Pro-SFTPB, which can be used for distinguishing whether a lung cancer patient suffers from a primary lung cancer or a metastatic lung cancer, and can also be used for determining whether a primary lung cancer has metastasized.
    Type: Application
    Filed: May 7, 2024
    Publication date: November 21, 2024
    Inventors: Junli GAO, Hong GUAN, Mingjie TONG, Junshun GAO, Xiaojun PENG, Weixin WANG
  • Publication number: 20240168024
    Abstract: The present disclosure provides a biomarker for detecting lung cancer and use thereof. A proteomics method is used to analyze a protein with significant differences in blood of a patient with lung cancer and normal people, such that a series of biomarkers capable of early predicting an occurrence risk of lung cancer are screened out, a group of biomarkers are further screened to construct a diagnosis model for lung cancer, and the model may be used for conveniently, non-invasively and effectively predicting whether an individual suffers from lung cancer or not, and meets clinical needs.
    Type: Application
    Filed: August 28, 2023
    Publication date: May 23, 2024
    Inventors: Junli GAO, Junshun GAO, Xiaojun PENG, Weixin WANG, Qinqin LOU, Hong GUAN